MKI67 and mantle cell lymphoma: The Ki67 proliferation index is a prognostic biomarker independent of sMIPI score and predicts survival in patients receiving chemotherapy and autologous stem cell transplant; a low Ki67 correlates with a more indolent form of MCL.